Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL).
Francesco GelsominoFrancesco GelsominoFausto BarbieriFerdinando RiccardiLuigi CavannaAntonio FrassoldatiAngelo DelmonteLucia LongoClaudio DazziSaverio CinieriIda ColantonioFrancesca SperandiGiuseppe LambertiStefano BrocchiLorenzo TofaniLuca BoniAndrea ArdizzoniPublished in: British journal of cancer (2020)
Clinical Trial registration number is ClinicalTrials.gov Identifier: NCT03219762.
Keyphrases